NRX Pharmaceuticals- Warrants (24/05/2026) Net Tangible Assets

NRX Pharmaceuticals- Warrants (24/05/2026) (NRXPW) currently reports a net tangible assets of $-170K as of June 2026. That compares with $-36M in the prior-year period — up 99.5% year over year. Use the charts on this page to explore NRX Pharmaceuticals- Warrants (24/05/2026)'s net tangible assets history and peer comparisons.

NRX Pharmaceuticals- Warrants (24/05/2026)'s net tangible assets increased from $-36M to $-170K — a 99.5% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

NRX Pharmaceuticals- Warrants (24/05/2026) reported $-170K in net tangible assets as of June 2026. That compares with $-36M in the prior-year period — up 99.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net tangible assets of $-170K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for NRX Pharmaceuticals- Warrants (24/05/2026), and consider following NRXPW for alerts when major investors trade the stock.

NRX Pharmaceuticals- Warrants (24/05/2026) is classified in the Healthcare sector. On net tangible assets, it currently shows $-170K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing NRXPW with unrelated industries.